Recent findings suggest that physicians affiliated with private equity investors may offer cost-effective, high-quality care compared to their counterparts in hospital and corporate-owned settings. This conclusion stems from a study commissioned by the American Independent Medical Practice Association (AIMPA), which examined the implications of various practice models across multiple specialties, including cardiology, gastroenterology, medical oncology, orthopedics, and urology.
The Growth of Private Equity in Healthcare
Between 2019 and 2022, private equity investment in healthcare surged, particularly as management services organizations began collaborating with private equity-affiliated private practices (PEAPPs). This growth has been largely attributed to the desire for more efficient healthcare delivery models and the recognition of the limitations faced by traditional healthcare systems.
The rise of private equity in healthcare is not merely a financial trend; it reflects broader shifts in the healthcare landscape. With increasing pressures to control costs and improve care quality, private equity firms have sought opportunities within healthcare to invest in practices that promise better patient outcomes and operational efficiencies.
Financial Implications for Medicare Patients
The AIMPA study highlights significant financial implications for Medicare patients treated by various practice models. According to the data collected, Medicare expenditures per beneficiary per year (PBPY) varied across different practice settings in 2022:
- Unaffiliated Private Practice (UPP): $26,996
- Private Equity Affiliated Practices (PEAPP): $27,421
- Corporate Practices: $27,796
- Hospital Practices: $30,416
These figures illustrate that while UPP physicians had the lowest expenditures, PEAPPs were not far behind, indicating that private equity investment may bolster efficiency in care delivery without excessively inflating costs. The close expenditure rates of UPPs and PEAPPs suggest that independent practices can maintain a competitive edge in terms of cost-effectiveness, even when aligned with private equity.
Specialty Breakdown of Costs
When breaking down expenditures by specialty, the findings remain consistent. PEAPP physicians ranked second-lowest in Medicare expenditures for most specialties, including cardiology, gastroenterology, medical oncology, and urology. Notably, hospital-affiliated physicians reported the highest number of inpatient days, implying that patients in these settings often require more intensive and costly care.
This disparity in healthcare expenditures raises important questions about the efficiency of hospital systems compared to private practices. It appears that hospital-affiliated physicians may resort to more aggressive treatment strategies, leading to higher costs without necessarily improving patient outcomes.
Quality of Care: A Closer Look
The study’s findings resonate with claims made by independent physicians, who argue that their practices provide high-quality care at lower costs than their hospital-affiliated counterparts. Dr. Paul Berggreen, President and Board Chair of AIMPA, stated in a news release, “This study supports our hypothesis—and illustrates how private equity investment can be a force for good in our healthcare system.”
Reduced Medicare Spending and Hospital Stays
Dr. Jack Feltz, chair of AIMPA’s Federal Health Policy Committee, emphasized that the data indicates a trend where independent practices linked to private equity lead to reduced Medicare spending and shorter hospital stays. “When independent practices affiliate with private equity-backed entities, Medicare spending goes down, and patients spend less time in the hospital,” he noted. “Those are trends policymakers should encourage.”
This trend suggests that private equity can contribute positively to healthcare delivery by enabling practices to maintain a focus on cost-effective care. With reduced inpatient days and lower Medicare expenditures, patients can potentially experience better health outcomes while navigating a less financially burdensome healthcare system.
Trends in Ownership Models
The AIMPA study also highlights a concerning trend in the healthcare landscape: the decline of unaffiliated private practice. Between 2019 and 2022, the proportion of physicians in UPP significantly decreased across the studied specialties. As of 2022, only 12% of physicians remained unaffiliated, a stark contrast to the increasing affiliations with private equity, hospitals, and corporate entities.
Decline of Unaffiliated Private Practice
The decline in UPP physicians raises alarms about the sustainability of independent practice in the current healthcare environment. As corporate entities and hospitals continue to acquire more practices, the independence of healthcare providers diminishes, potentially limiting patient choice and access to personalized care.
Percentage of UPP Physicians by Specialty:
- Medical Oncology: 5%
- Urology: 16%
- Orthopedics: Decreased from 39% to 14%
Interestingly, while it may seem that private equity investors are swallowing up medical practices, only 6% of physicians across the five specialties studied were affiliated with PEAPP models. In contrast, corporate entities and hospitals maintained ownership of a combined 82% of physician practices. This data points to a significant concentration of power within hospital systems and corporate entities, which could further exacerbate challenges faced by independent practices.
Implications for the Future
The AIMPA study, conducted by healthcare consultant Avalere, presents valuable insights into the dynamics of healthcare delivery. While it is essential to note the study’s limitations—such as its focus on Medicare fee-for-service data and a limited number of specialties—the findings contribute to an ongoing conversation about the role of private equity in healthcare.
As healthcare continues to evolve, understanding the impact of different ownership models on patient care and cost-effectiveness is crucial. This study suggests that private equity could play a beneficial role in the healthcare system by enhancing competition and encouraging independent practice, ultimately benefiting patients and the broader healthcare landscape.
Enhancing Competition in Healthcare
One of the most significant implications of this research is the potential for private equity to enhance competition within the healthcare system. By supporting independent practices, private equity investments can foster an environment where providers are incentivized to deliver high-quality, cost-effective care. This competition can lead to improved patient outcomes and more efficient use of healthcare resources.
The Challenge of Balancing Profit and Patient Care
However, it is essential to approach the integration of private equity into healthcare with caution. While the study indicates positive trends, the overarching concern remains the balance between profit-driven motives and patient care. Policymakers and healthcare leaders must ensure that the pursuit of profits does not compromise the quality of care provided to patients.
Regulatory Oversight
In light of the growing influence of private equity in healthcare, regulatory oversight will be critical in maintaining quality standards and ensuring patient safety. Policymakers should consider implementing measures to monitor the performance of private equity-affiliated practices and evaluate their impact on patient outcomes.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
